Search results

There is one critical difference. Every impurity that develops in pharma peptides has to be specifically characterized and assessed for risk. Impurities that are high risk to health must be eliminated. All of this is heavily documented and reviewed by the FDA. The types of impurities that...

PT-141 at low doses tends to induce all the side effects without the libido enhancing benefits, leading to disappointment and prematurely giving up. Vyleesi, the same compound in FDA approved pharma form for Women with unattractive partners, comes as a 1.75mg pen. There is no "starting low" for...

8x a month per FDA guidance.

No, the sterility testing protocol doesn't involve filtration.

It has nothing to do with the size of the peptide molecule. It's about the microorganisms and other contaminants that would otherwise be removed at .22um that pass through a .45um filter. This additional material reduces purity calculations.

That's interesting. It means compared to labs using .22um filters, the same sample results from TP could be expected to show a lower purity.

6 months of 2mg a day Tesamorelin will significantly reduce visceral fat. You need to be dieting (with or without a GLP) and/or exercising to put yourself into a calorie deficit or the visceral fat will be replaced by an equivalent amount of subcutaneous fat elsewhere. It's "weight neutral".

It doesn't seem to be a commonly understood limitation of the type of testing we have access to. The standard in science, pharma, and regulatory agencies requires multiple methods of testing peptide drugs for contamination since they all have "blind spots" that need to be compensated for. The...

Every "purity" test you see of UGL peptides is conducted AFTER being filtered with a .22um syringe filter. Contaminants larger than that, which are common, are removed first. Unless you're filtering first, you're not injecting what you see in the test result, but the "raw" version with some...